Darifenacin or darifenacin hydrobromide

A fluorinated analog of AEA that serves as a substrate of FAAH (Km = 29 &microM) used to perform n-FABS against FAAH to identify novel inhibitors.

A fluorinated analog of AEA that serves as a substrate of FAAH (Km = 29 &microM) used to perform n-FABS against FAAH to identify novel inhibitors.

Assgn. Overly 12Ch

InformationBelvarafenib (GDC5573, HM95573, RG6185) is a selective and orally bioavailablepan-RAF kinaseinhibitor with IC50 values of 41 nM, 7 nM and 2 nM for BRAF WT, BRAF(V600E) and CRAF kinases, respectively.TargetsCRAF (Cell-free assay): BRAF

InformationBelvarafenib (GDC5573, HM95573, RG6185) is a selective and orally bioavailablepan-RAF kinaseinhibitor with IC50 values of 41 nM, 7 nM and 2 nM for BRAF WT, BRAF(V600E) and CRAF kinases, respectively.TargetsCRAF (Cell-free assay): BRAF

InformationBelvarafenib (GDC5573, HM95573, RG6185) is a selective and orally bioavailablepan-RAF kinaseinhibitor with IC50 values of 41 nM, 7 nM and 2 nM for BRAF WT, BRAF(V600E) and CRAF kinases, respectively.TargetsCRAF (Cell-free assay): BRAF

InformationBelvarafenib (GDC5573, HM95573, RG6185) is a selective and orally bioavailablepan-RAF kinaseinhibitor with IC50 values of 41 nM, 7 nM and 2 nM for BRAF WT, BRAF(V600E) and CRAF kinases, respectively.TargetsCRAF (Cell-free assay): BRAF

InformationBFH772 is a novel potent oralVEGFR2inhibitor, targeting VEGFR2 kinase with IC50 of 3 nM.TargetsVEGFR2 (Cell-free assay) 3 nMIn vitroBFH772 was highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM, however, lost 500-fold

InformationBFH772 is a novel potent oralVEGFR2inhibitor, targeting VEGFR2 kinase with IC50 of 3 nM.TargetsVEGFR2 (Cell-free assay) 3 nMIn vitroBFH772 was highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM, however, lost 500-fold

InformationBFH772 is a novel potent oralVEGFR2inhibitor, targeting VEGFR2 kinase with IC50 of 3 nM.TargetsVEGFR2 (Cell-free assay) 3 nMIn vitroBFH772 was highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM, however, lost 500-fold

InformationBFH772 is a novel potent oralVEGFR2inhibitor, targeting VEGFR2 kinase with IC50 of 3 nM.TargetsVEGFR2 (Cell-free assay) 3 nMIn vitroBFH772 was highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM, however, lost 500-fold

InformationBFH772 is a novel potent oralVEGFR2inhibitor, targeting VEGFR2 kinase with IC50 of 3 nM.TargetsVEGFR2 (Cell-free assay) 3 nMIn vitroBFH772 was highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM, however, lost 500-fold